Similarly, paraoxonase-1 (PON1) is a liver derived antioxidant enzyme which is has been shown to be diminished in NAFLD [14–18] and was significantly decreased in hyperglycemic vs. normoglycemic HepG2 cells. The gene discussed is PON1; the disease is metabolic dysfunction-associated steatotic liver disease.